| 產(chǎn)品名稱 | Sumatriptan succinate - GR 43175 | GW 102 | SN 308 |
| 產(chǎn)品貨號 | Axon 1352 CAS [103628-48-4] MF C14H21N3O2S.C4H6O4MW 413.49 Purity: 99% Soluble in DMSO Description Selective 5-HT1B/1D receptor agonist indicated for the treatment of migraine headaches References Certificates Categories Extra info Sumatriptan. WHO Drug Information 1988, 2(2), 111. ? C De Battista and K Mueller. Sumatriptan prophylaxis for postelectroconvulsive therapy headaches. Headache 1995, 35(8), 502-503. ? Z Razzaque et al. Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation. Br J Clin Pharmacol 1999, 47(1), 75–82. Certificate of Analysis Material Safety Data Sheet CNS 5-HT1B 5-HT1D A19 5-HT1B and 5-HT1D agonist Chemical name 1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide succinate Parent CAS No. [103628-46-2] Order Size Unit Price Stock 10 mg €85.00 In Stock |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Sumatriptan succinate - GR 43175 | GW 102 | SN 308Axon 1352 CAS [103628-48-4] MF C14H21N3O2S.C4H6O4
Description
Selective 5-HT1B/1D receptor agonist indicated for the treatment of migraine headaches
5-HT1B and 5-HT1D agonist
Chemical name1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide succinate Parent CAS No.[103628-46-2] |
| 產(chǎn)品資料 |
